BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31714185)

  • 1. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
    Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
    J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
    Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
    Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
    Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
    Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
    J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
    Xu Y; Zhao S; Cui M; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circ_0004463/miR-380-3p/FOXO1 axis modulates mitochondrial respiration and bladder cancer cell apoptosis.
    Wu S; Deng H; He H; Xu R; Wang Y; Zhu X; Zhang J; Zeng Q; Zhao X
    Cell Cycle; 2020 Dec; 19(24):3563-3580. PubMed ID: 33283616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.
    Jiang G; Huang C; Li J; Huang H; Jin H; Zhu J; Wu XR; Huang C
    Mol Cancer Ther; 2017 May; 16(5):924-935. PubMed ID: 28223425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
    J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
    Zhang Q; Zhuang J; Deng Y; Zhao X; Tang B; Yao D; Zhao W; Chang C; Lu Q; Chen W; Zhang S; Ji C; Cao L; Guo H
    Oncotarget; 2015 Oct; 6(31):32177-92. PubMed ID: 26375441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene.
    Yu J; Ni Q; Zhang S; Hua R; Tao R; Tang C; Feng S
    Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):95-100. PubMed ID: 32359391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel protective role for microRNA-3135b in Golgi apparatus fragmentation induced by chemotherapy via GOLPH3/AKT1/mTOR axis in colorectal cancer cells.
    Núñez-Olvera SI; Chávez-Munguía B; Del Rocío Terrones-Gurrola MC; Marchat LA; Puente-Rivera J; Ruíz-García E; Campos-Parra AD; Vázquez-Calzada C; Lizárraga-Verdugo ER; Ramos-Payán R; Salinas-Vera YM; López-Camarillo C
    Sci Rep; 2020 Jun; 10(1):10555. PubMed ID: 32601379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.